Page 23 - தகவல்கள் பாதுகாப்பு கண்காணிப்பு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Andrew Pollard, Professor of Paediatric Infection and Immunity, said: ‘Safety has been our priority throughout the development of the vaccine at Oxford University in 2020, and we are reassured to see that safety monitoring continues under the close scrutiny of regulators and public health authorities as the vaccine is rolled out around the world. ‘The identification of rare cases of blood clots, which might be associated with the vaccine, shows that the safety system works, and has also allowed MHRA and EMA to conclude that the benefits of vaccination continue to outweigh the risks, while putting in measures to help mitigate any possible risk.

United kingdomAndrew pollardOxford astrazenecaEu european medicines agencyCommittee on vaccinationOxford universityRegulatory agencyMedicines agencyPaediatric infectionJoint committeeData safety monitoring boardஒன்றுபட்டது கிஂக்டம்ஆண்ட்ரூ பொழிலர்ட்குழு ஆன் தடுப்பூசிஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்குழந்தை தொற்று